Company Information

Company Optima Pharmazeutische GmbH
www.optimapharma.de
Type:
SME
Country:
Germany
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Privately Held
Global Compact Status:
Active
Participant Since
05 May 2014
Letter of Commitment
Next Communication on Progress (COP) due on:
15 July 2023

Communication On Progress

Published On Title Level
2022-05-05 Optima Pharma Sustainability Report Active
2021-05-07 Optima - Sustainability Report 2021 Active
2020-05-08 Optima - Sustainability Report 2020 Active
2019-05-08 Optima - Sustainability Report 2019 Active
2018-05-08 Optima - Sustainability Report 2018 Active
2017-05-08 Optima - Sustainability Report 2017 Active
2016-05-06 Sustainability Report 2015 / UNGC COP Active
2015-05-05 Sustainability Report 2015 / UNGC COP Active

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.